Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:775-780, doi:10.1016/S0735-1097(03)00829-5
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, K.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, K.-L.

CLINICAL STUDY

A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis

Kwan-Leung Chan, MD, FRCPC, FACC*,*, Jean G. Dumesnil, MD, FRCPC{dagger}, Bibiana Cujec, MD, FRCPC{ddagger}, Anthony J. Sanfilippo, MD, FRCPC§, John Jue, MD, FRCPC||, Michele A. Turek, MD, FRCPC*, Trevor I. Robinson, MD, David Moher, MSc* Investigators of the Multicenter Aspirin Study in Infective Endocarditis

* Department of Medicine, University of Ottawa and University of Ottawa Heart Institute, Ottawa, Canada
{dagger} Institut de Cardiologie de Québec, Ste-Foy, Quebec, Canada
{ddagger} Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
§ Department of Medicine, Queen's University, Kingston, Ontario, Canada
|| Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Manuscript received December 4, 2002; revised manuscript received March 4, 2003, accepted March 12, 2003.

* Reprint requests and correspondence: Dr. Kwan-Leung Chan, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada K1Y 4W7.
kchan{at}ottawaheart.ca

OBJECTIVES: This study examined the effect of aspirin on the risk of embolic events in infective endocarditis (IE).

BACKGROUND: Embolism is a major complication of IE, and studies in animal models have shown that platelet inhibition with aspirin can lead to more rapid vegetation resolution and a lower rate of embolic events.

METHODS: We conducted a randomized, double-blinded, placebo-controlled trial of aspirin treatment (325 mg/day) for four weeks in patients with IE to test the hypothesis that the addition of aspirin would reduce the incidence of clinical systemic embolic events. Patients with perivalvular abscess were excluded. Serial cerebral computed tomograms and transesophageal echocardiograms were obtained in a subset of patients.

RESULTS: During the four-year study period, 115 patients were enrolled: 60 assigned to aspirin and 55 assigned to placebo. Embolic events occurred in 17 patients (28.3%) on aspirin and 11 patients (20.0%) on placebo, with an odds ratio (OR) of 1.62 (95% confidence interval [CI] 0.68 to 3.86, p = 0.29). There was a trend toward a higher incidence of bleeding in the patients taking aspirin versus placebo (OR 1.92, 95% CI 0.76 to 4.86, p = 0.075). Development of new intracranial lesions was similar in both groups. Aspirin had no effect on vegetation resolution and valvular dysfunction.

CONCLUSIONS: In endocarditis patients already receiving antibiotic treatment, the addition of aspirin does not appear to reduce the risk of embolic events and is likely associated with an increased risk of bleeding. Aspirin is not indicated in the early management of patients with IE.

Abbreviations and Acronyms
  CI
  confidence interval
  IE
  infective endocarditis
  OR
  odds ratio




This article has been cited by other articles:


Home page
Eur Heart JHome page
Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al.
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)
Eur. Heart J., October 1, 2009; 30(19): 2369 - 2413.
[Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
W. G. Daniel and F. A. Flachskampf
CHAPTER 22 Infective Endocarditis
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263.
[Full Text] [PDF]


Home page
CirculationHome page
C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al.
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, December 2, 2008; 118(23): e714 - e833.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.-F. Tripodi, B. Barsic, E. Bouza, C. H. Cabell, A. I. d. O. Ramos, V. Fowler Jr, B. Hoen, et al.
Current Features of Infective Endocarditis in Elderly Patients: Results of the International Collaboration on Endocarditis Prospective Cohort Study
Arch Intern Med, October 27, 2008; 168(19): 2095 - 2103.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker
Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 593S - 629S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. W. Sy, C. Chawantanpipat, D. R. Richmond, and L. Kritharides
Thrombocytopenia and Mortality in Infective Endocarditis
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1824 - 1825.
[Full Text] [PDF]


Home page
HeartHome page
B D Prendergast
The changing face of infective endocarditis
Heart, July 1, 2006; 92(7): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. M. Baddour, W. R. Wilson, A. S. Bayer, V. G. Fowler Jr, A. F. Bolger, M. E. Levison, P. Ferrieri, M. A. Gerber, L. Y. Tani, M. H. Gewitz, et al.
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Circulation, June 14, 2005; 111(23): e394 - e434.
[Abstract] [Full Text] [PDF]


Home page
Journal of Diagnostic Medical SonographyHome page
P. J. Peters
Infective Endocarditis
Journal of Diagnostic Medical Sonography, May 1, 2005; 21(3): 192 - 204.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The year in valvular heart disease
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. L. Connolly, A. Choudhury, R. C. Davis, and G. Y. H. Lip
A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1134 - 1135.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement